Health Trials

Dermatofibrosarcoma Protuberans (DFSP)

2

Review clinical trials related to Dermatofibrosarcoma Protuberans (DFSP). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans

This study aims to evaluate the efficacy and safety of toripalimab and anlotinib hydrochloride combined with standard chemotherapy in patients with refractory dermatofibrosarcoma protuberans (DFSP) resistant to imatinib therapy, and to provide evidence for the exploration of DFSP treatment.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Yanjie Zhang, MDUpdated: Jun 16, 2026
Eligibility criteria

Male or female patients aged ≥18 years. [+12]

Spinal cord compression, leptomeningeal disease, or clinically active central ne... [+7]

Read more
Status: Not yet recruiting

NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique

This research study will evaluate how near-infrared fluorescence (NIRF) imaging with low-dose second window indocyanine green (ICG) can assist in the radical resection and pathologic diagnosis of malignant soft tissue sarcoma, such as dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC) during surgery.

Participants needed: 592
Trial details
Phase: Phase 1Biological sex: AllType: InterventionalSponsor: The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeUpdated: Sep 24, 2024
Eligibility criteria

Patients with DFSPs or sSCC in heads, extremities or trunk

seafood/iodine allergy [+4]

Read more